News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Beth Whitehouse, Newsday | 06.14.2004

Up until now, Sharla Miller's life could pretty much be titled "My Three Sons." Nature dealt her boy after boy...

By Carl T. Hall, San Francisco Chronicle | 06.04.2004

A $3 billion state proposition to promote controversial stem cell research in California qualified Thursday for the November ballot, opening...

By Research! America/Parade, Research! America/Parade | 06.01.2004

Therapeutic cloning is the use of cloning technology to help in the search for possible cures and treatments for diseases...

By Kristy Evans and Ann Elisabeth S. Samson, AWID Facts and Issues | 05.31.2004
By Marcy Darnovsky | 05.07.2004

Presentation at Gender and Justice in the Gene Age, New York, NY

I'm going to focus on two questions:

1...

By Marcy Darnovsky | 05.06.2004

Presentation at Gender and Justice in the Gene Age, New York, NY

Welcome and thanks to every one for...

By Gallup, Gallup | 05.02.2004

Regardless of whether or not you think it should be legal, please tell me if you personally believe that in...

By Richard Hayes, San Francisco Chronicle | 04.04.2004

You wouldn't know it from the charged partisan debate here in the United States, but throughout the world new policies...